Impacto terapéutico de las estatinas en el perfil lipídico y el riesgo cardiovascular en pacientes con lupus eritematoso sistémico: revisión sistemática de la literatura y metaanálisis

Reumatología Clínica - Tập 15 - Trang e86-e91 - 2019
Paula Sánchez1, Esteban Toro-Trujillo1, Oscar M. Muñoz-Velandia2, Angel Alberto García3, Daniel G. Fernández-Ávila4
1Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
2Departamento de Medicina Interna, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
3Departamento de Medicina Interna, Unidad de Cardiología, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
4Departamento de Medicina Interna, Unidad de Reumatología, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia

Tài liệu tham khảo

Sherer, 2010, Atherosclerosis in systemic lupus erythematosus, Autoimmunity., 43, 98, 10.3109/08916930903374527 Soubrier, 2013, Do all lupus patients need statins?, Joint Bone Spine., 80, 244, 10.1016/j.jbspin.2012.08.014 Petri, 2011, Lupus Atherosclerosis Prevention Study (LAPS), Ann Rheum Dis., 70, 760, 10.1136/ard.2010.136762 Stojan, 2013, Atherosclerosis in systemic lupus erythematosus, J Cardiovasc Pharmacol, 62, 255, 10.1097/FJC.0b013e31829dd857 Batún Garrido, 2016, Riesgo cardiovascular en lupus eritematoso sistémico, Rev Colomb Reumatol, 23, 242 Urowitz, 2008, Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort, Arthritis Rheum., 59, 176, 10.1002/art.23353 Fatemi, 2014, Atorvastatin effect on systemic lupus erythematosus disease activity: A double-blind randomized clinical trial, Clin Rheumatol., 33, 1273, 10.1007/s10067-014-2654-7 Ferreira, 2007, Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: An 8 weeks controlled trial, Rheumatology (Oxford)., 46, 1560, 10.1093/rheumatology/kem186 Petri, 2012, Derivation and validation of Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum., 64, 2677, 10.1002/art.34473 Scottish Intercollegiate Guidelines Network. Checklist. Edinburg: SIGN; 2014. Plazak, 2011, Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients, Inflamm Res [Internet]., 60, 973, 10.1007/s00011-011-0358-x Mok, 2011, Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: A randomized, double-blind, placebo-controlled trial, Arthritis Care Res., 63, 875, 10.1002/acr.20440 Hong, 2008, The effects of rosuvastatin on plaque regression in patients who have a mild to moderate degree of coronary stenosis with vulnerable plaque, Korean Circ J., 38, 366, 10.4070/kcj.2008.38.7.366 Sokoll, 2014, Effects of atorvastatin on atherosclerosis and atherogenesis in systemic lupus erythematosus: A pilot study, ISRN Immunol., 2014, 10.1155/2014/295239 Mihaylova, 2012, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials, Lancet., 380, 581, 10.1016/S0140-6736(12)60367-5